Hyperbilirubinaemia, presenting as jaundice, is a ubiquitous and frequently benign
condition in newborn babies but is a leading cause of hospitalisation in the first week of life …

Background: Rhesus (Rh) disease and extreme hyperbilirubinemia (EHB) result in neonatal
mortality and long-term neurodevelopmental impairment, yet there are no estimates of their …

OBJECTIVE: To test whether the combined use of total plasma/serum bilirubin (TSB) levels
and clinical risk factors more accurately identifies infants who receive phototherapy than …

Importance Neonatal hyperbilirubinemia can cause lifelong neurodevelopmental
impairment (kernicterus) even in high-resource settings. A better understanding of the …

A breakthrough discovery 60 years ago by Cremer et al. has since changed the way we treat
infants with hyperbilirubinemia and saved the lives of millions from death and disabilities.“ …

We provide an approach to the use of phototherapy and exchange transfusion in the
management of hyperbilirubinemia in preterm infants of< 35 weeks of gestation. Because …

Despite efforts to eliminate permanent and irreversible brain damage due to bilirubin
encephalopathy and kernicterus, these conditions continue to accompany us into the third …

OBJECTIVES: To examine the association between early discharge from hospital after birth
and readmission to hospital for jaundice among term infants, and among infants discharged …

Aim Neonatal jaundice is an important cause of morbidity and mortality, and identifying the
condition remains a challenge. This study evaluated a novel method of estimating bilirubin …

Neonatal jaundice (NJ) is common in newborn infants. Severe NJ (SNJ) has potentially
negative neurological sequelae that are largely preventable in high resource settings if …